Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to a new study.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

It’s an FDA-approved injection you take weekly. Saxenda (liraglutide) is another injectable GLP-1 that’s FDA-approved for weight loss/management. Saxenda is injected daily or twice daily ...

Medically reviewed by Anju Goel, MD Many peptide medications like glucagon-like peptide-1 (GLP-1) receptor agonists were ...

Drugs like Ozempic, Mounjaro and Saxenda have swept the globe since emerging on the market late last decade, and an estimated 20,000 Australians currently use the drugs for weight loss.

Saxenda (liraglutide) is a GLP-1 that increases feelings of fullness while decreasing feelings of hunger. It has FDA approval for weight loss, unlike Ozempic, which only has approval for type 2 ...